Jones Financial Companies’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5M Sell
66,747
-8,431
-11% -$575K ﹤0.01% 1192
2026
Q1
$4.63M Buy
75,178
+72,610
+2,827% +$5.12M ﹤0.01% 1101
2025
Q4
$173K Buy
2,568
+286
+13% +$19.2K ﹤0.01% 1970
2025
Q3
$168K Buy
2,282
+477
+26% +$31.7K ﹤0.01% 1859
2025
Q2
$94.2K Buy
1,805
+507
+39% +$28.8K ﹤0.01% 1960
2025
Q1
$82.9K Buy
1,298
+732
+129% +$42.5K ﹤0.01% 1860
2024
Q4
$27.1K Buy
566
+130
+30% +$6.67K ﹤0.01% 2122
2024
Q3
$24.8K Buy
436
+55
+14% +$3.15K ﹤0.01% 1875
2024
Q2
$19.9K Buy
+381
New +$16.7K ﹤0.01% 1536

Other funds holding HALO

Jones Financial Companies's HALO Position: Q2 2026 in Review

Jones Financial Companies reduced its Halozyme (HALO) stake by 11% in Q2 2026, selling an estimated $575K and leaving 66,747 shares worth $5M. The position accounts for ﹤0.01% of the portfolio, ranked #1192.

Jones Financial Companies first reported a position in HALO in Q2 2024 and has held it in 9 quarters since. 674 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Jones Financial Companies held 66,747 shares of Halozyme worth $5M as of Q2 2026.
  • Jones Financial Companies sold 8,431 Halozyme shares in Q2 2026, an estimated $575K.
  • Halozyme made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #1192 holding.
  • Jones Financial Companies first reported a position in Halozyme in Q2 2024 and has held it in 9 quarters since.
  • 674 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.